We provide you with 20 years of free, institutional-grade data for ARVN stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ARVN. Explore the full financial landscape of ARVN stock.
Total insider purchase within 3 month on this page: $227,010
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Morrison Briggs | Open Market Purchase | 30,000 | $7.57 | 2025-09-24 | |
| AGARWAL SUNIL | Grant, award...etc | 16,025 | 2025-06-30 | ||
| YOUNG JOHN D | Grant, award...etc | 16,025 | 2025-06-27 | ||
| Cunningham Everett | Grant, award...etc | 16,025 | 2025-06-27 | ||
| Bain Linda | Grant, award...etc | 16,025 | 2025-06-27 | ||
| Norwalk Leslie V | Grant, award...etc | 16,025 | 2025-06-27 | ||
| Kennedy Edward Moore Jr. | Grant, award...etc | 16,025 | 2025-06-27 | ||
| Smaldone Alsup Laurie | Grant, award...etc | 16,025 | 2025-06-27 | ||
| Morrison Briggs | Grant, award...etc | 16,025 | 2025-06-27 | ||
| Saik Andrew | Sale | -5,700 | $7.61 | $43,377 | 2025-06-24 |
| Cacace Angela M | Sale | -2,583 | $7.49 | $19,347 | 2025-06-18 |
| Berkowitz Noah | Grant, award...etc | 59,600 | 2025-05-13 | ||
| Loomis David K | Grant, award...etc | 11,825 | 2025-05-13 | ||
| Saik Andrew | Grant, award...etc | 59,600 | 2025-05-13 | ||
| Cacace Angela M | Grant, award...etc | 59,600 | 2025-05-13 | ||
| Berkowitz Noah | Sale | -8,658 | $8.59 | $74,372 | 2025-03-19 |
| Loomis David K | Sale | -1,214 | $16.75 | $20,335 | 2025-02-25 |
| Taylor Ian | Sale | -9,020 | $16.75 | $151,085 | 2025-02-25 |
| Houston John G | Sale | -31,338 | $16.75 | $524,912 | 2025-02-25 |
| Cacace Angela M | Sale | -4,207 | $16.75 | $70,467 | 2025-02-25 |
| Houston John G | Grant, award...etc | 152,000 | 2025-02-18 | ||
| Cacace Angela M | Grant, award...etc | 49,092 | 2025-02-18 | ||
| Saik Andrew | Grant, award...etc | 49,092 | 2025-02-18 | ||
| Loomis David K | Grant, award...etc | 10,584 | 2025-02-18 | ||
| Taylor Ian | Grant, award...etc | 20,619 | 2025-02-18 | ||
| Berkowitz Noah | Grant, award...etc | 55,229 | 2025-02-18 | ||
| Loomis David K | Sale | -460 | $17.05 | $7,843 | 2024-11-12 |
| Saik Andrew | Grant, award...etc | 61,409 | 2024-06-26 | ||
| Cacace Angela M | Initial | 2024-06-18 | |||
| Cacace Angela M | Grant, award...etc | 15,995 | 2024-06-18 | ||
| Morrison Briggs | Grant, award...etc | 5,899 | 2024-05-31 | ||
| Norwalk Leslie V | Grant, award...etc | 5,899 | 2024-05-31 | ||
| YOUNG JOHN D | Grant, award...etc | 5,899 | 2024-05-31 | ||
| Smaldone Alsup Laurie | Grant, award...etc | 5,899 | 2024-05-31 | ||
| Cunningham Everett | Grant, award...etc | 5,899 | 2024-05-31 | ||
| Kennedy Edward Moore Jr. | Grant, award...etc | 5,899 | 2024-05-31 | ||
| Bain Linda | Grant, award...etc | 5,899 | 2024-05-31 | ||
| AGARWAL SUNIL | Grant, award...etc | 5,899 | 2024-05-31 | ||
| Teel Randy | Grant, award...etc | 13,300 | 2024-05-23 | ||
| Berkowitz Noah | Grant, award...etc | 63,452 | 2024-03-21 | ||
| Teel Randy | Initial | 2024-03-19 | |||
| Loomis David K | Grant, award...etc | 5,750 | 2024-02-27 | ||
| Taylor Ian | Sale | -1,701 | $47.05 | $80,032 | 2024-02-27 |
| Taylor Ian | Grant, award...etc | 39,250 | 2024-02-27 | ||
| Peck Ronald | Sale | -1,699 | $47.05 | $79,938 | 2024-02-27 |
| Peck Ronald | Grant, award...etc | 39,250 | 2024-02-27 | ||
| Houston John G | Sale | -5,196 | $47.05 | $244,472 | 2024-02-27 |
| Houston John G | Grant, award...etc | 124,450 | 2024-02-27 | ||
| Cassidy Sean A | Sale | -1,702 | $47.05 | $80,079 | 2024-02-27 |
| Taylor Ian | Derivatives Exercise | 8,252 | 2024-01-08 | ||
| Peck Ronald | Sale | -1,324 | $24.39 | $32,289 | 2023-08-14 |
| Peck Ronald | Derivatives Exercise | 4,010 | 2023-08-14 | ||
| AGARWAL SUNIL | Grant, award...etc | 8,242 | 2023-06-20 | ||
| YOUNG JOHN D | Grant, award...etc | 4,121 | 2023-06-20 | ||
| Smaldone Alsup Laurie | Grant, award...etc | 4,121 | 2023-06-20 | ||
| Norwalk Leslie V | Grant, award...etc | 4,121 | 2023-06-20 | ||
| Morrison Briggs | Grant, award...etc | 4,121 | 2023-06-20 | ||
| Kennedy Edward Moore Jr. | Grant, award...etc | 4,121 | 2023-06-20 | ||
| DIXON WENDY L | Grant, award...etc | 4,121 | 2023-06-20 | ||
| Bain Linda | Grant, award...etc | 4,121 | 2023-06-20 | ||
| Cunningham Everett | Grant, award...etc | 4,121 | 2023-06-20 | ||
| Taylor Ian | Sale | -1,051 | $29.53 | $31,036 | 2023-03-03 |
| Taylor Ian | Derivatives Exercise | 2,685 | 2023-03-03 | ||
| Houston John G | Sale | -5,878 | $29.53 | $173,577 | 2023-03-03 |
| Houston John G | Derivatives Exercise | 17,510 | 2023-03-03 | ||
| Cassidy Sean A | Sale | -1,745 | $29.53 | $51,530 | 2023-03-03 |
| Cassidy Sean A | Derivatives Exercise | 4,791 | 2023-03-03 | ||
| Cassidy Sean A | Grant, award...etc | 19,125 | 2023-02-24 | ||
| Peck Ronald | Grant, award...etc | 19,125 | 2023-02-24 | ||
| Taylor Ian | Grant, award...etc | 19,125 | 2023-02-24 | ||
| Houston John G | Grant, award...etc | 61,975 | 2023-02-24 | ||
| Loomis David K | Initial | 2022-12-23 | |||
| Cunningham Everett | Grant, award...etc | 30,095 | 2022-12-19 | ||
| Peck Ronald | Sale | -2,516 | $54.84 | $137,988 | 2022-08-16 |
| Peck Ronald | Derivatives Exercise | 8,020 | 2022-08-16 |
The information provided in this report about ARVN stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Arvinas, Inc(NASDAQ:ARVN) 
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates are ARV-110, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical tri...
Website: http://www.arvinas.com
Founded: 2013
Full Time Employees: 133
Sector: Healthcare
Industry: Biotechnology